Skip to Main Content

Paper Details

Patient-Specific Targeting of the T-Cell Receptor Variable Region as a Therapeutic Strategy in Clonal T-Cell Diseases.
Clin Cancer Res
0
2023
Author NameAffiliation
Olivia M LuceroOregon Health & Science University
Olivia M LuceroKnight Cancer Institute, Oregon Health & Science University
Kara JohnsonKnight Cancer Institute, Oregon Health & Science University
Kara JohnsonOregon Health & Science University
Guang FanDepartment of Pathology and Clinical Laboratory Medicine, Oregon Health & Science University
Bill H ChangKnight Cancer Institute, Oregon Health & Science University
Bill H ChangOregon Health & Science University
Christopher A EideKnight Cancer Institute, Oregon Health & Science University
Christopher A EideOregon Health & Science University
Mike PalazzoloClinical and Translational Science Institute, David Geffen School of Medicine, University of California los angeles
Evan F LindKnight Cancer Institute, Oregon Health & Science University
Evan F LindOregon Health & Science University
Evan F LindOregon Health & Science University
Yoko KosakaKnight Cancer Institute, Oregon Health & Science University
Yoko KosakaOregon Health & Science University
Brian J DrukerKnight Cancer Institute, Oregon Health & Science University
Brian J DrukerOregon Health & Science University
Brian J DrukerVB Therapeutics LLC
  • 1 - 18

Datasets

Release 1.2